Details for Patent: 8,324,225
Which drugs does patent 8,324,225 protect, and when does it expire?
Patent 8,324,225 protects KISQALI and KISQALI FEMARA CO-PACK (COPACKAGED) and is included in two NDAs.
Protection for KISQALI has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.
This patent has forty-seven patent family members in thirty-eight countries.
Summary for Patent: 8,324,225
| Title: | Pyrrolopyrimidine compounds and their uses |
| Abstract: | The present application describes organic compounds that are useful for the treatment, prevention and/or amelioration of diseases, particularly pyrrolopyrimidine compounds and derivatives are described which inhibit protein kinases. The organic compounds are useful in treating proliferative disease. |
| Inventor(s): | Christopher Thomas Brain, Moo Je Sung, Gebhard Thoma |
| Assignee: | Astex Therapeutics Ltd , Novartis Pharmaceuticals Corp |
| Application Number: | US12/302,223 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 8,324,225 |
|
Patent Claim Types: see list of patent claims | Composition; Compound; |
Drugs Protected by US Patent 8,324,225
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Novartis | KISQALI | ribociclib succinate | TABLET;ORAL | 209092-001 | Mar 13, 2017 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | Y | ⤷ Start Trial | ||||
| Novartis | KISQALI FEMARA CO-PACK (COPACKAGED) | letrozole; ribociclib succinate | TABLET;ORAL | 209935-001 | May 4, 2017 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | Y | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 8,324,225
| PCT Information | |||
| PCT Filed | May 24, 2007 | PCT Application Number: | PCT/US2007/069595 |
| PCT Publication Date: | December 06, 2007 | PCT Publication Number: | WO2007/140222 |
International Family Members for US Patent 8,324,225
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Argentina | 061124 | ⤷ Start Trial | |||
| Argentina | 108179 | ⤷ Start Trial | |||
| Australia | 2007267645 | ⤷ Start Trial | |||
| Brazil | PI0712816 | ⤷ Start Trial | |||
| Canada | 2652044 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
